# The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019, Regulation 20: Amendment of regulation 45 (suspension and revocation of manufacturing authorisation)

Extent: E+W+S+N.I.

In regulation 45(1)(f)(i), for “or any equivalent provisions in any EEA State other than the United Kingdom” substitute “or, in the case of an investigational medicinal product manufactured or assembled in Northern Ireland, any equivalent provisions in any EEA State”. .

---
Source: https://www.legislation.gov.uk/uksi/2019/744/regulation/20 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-amendment-eu-exit-regulations-2019/regulation-20
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.